Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice

Published:2010-10 Issue:2 Volume:212 Page:472-480
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Lu Xinjie,Chen Daxin,Endresz Valeria,Xia Min,Faludi Ildiko,Burian Katalin,Szabo Andrea,Csanadi Agnes,Miczak Andras,Gonczol Eva,Kakkar Vijay

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Inflammation, atherosclerosis, and coronary artery disease;Hansson;N Engl J Med,2005

2. Natural regulatory T cells control the development of atherosclerosis in mice;Ait-Oufella;Nat Med,2006

3. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis;Schiopu;Circulation,2004

4. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL;Binder;Nat Med,2003

5. Immunomodulation of atherosclerosis: implications for vaccine development;Nilsson;Arerioscler Thromb Vasc Biol,2005

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two decades of vaccine development against atherosclerosis;Nano Today;2023-06

2. Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance;Frontiers in Cardiovascular Medicine;2022-07-28

3. Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China;Medical Science Monitor;2022-03-29

4. Vaccination against Atherosclerosis: Is It Real?;International Journal of Molecular Sciences;2022-02-22

5. Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus;Vascular Pharmacology;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3